First, due to the nature of the observational, single-arm, pre- and post-index study design, we are unable to reach any conclusions around causality, including but not limited to limitations on temporal relationships and confounding bias
Compounded Semaglutide is suitable for many individuals seeking weight loss, but its not right for everyone
Preclinical and in vitro models can show how a compound behaves in a controlled research setting
Unlike Medicare, Medicaid can cover weight loss drugs, treatments, and even surgery, but the rules vary by state
Importantly, the observed LBM reduction has not consistently translated into functional impairment, and emerging evidence suggests that GLP-1 RAs may counterbalance this effect by improving muscle quality and metabolism [21]